MARKET

LGVN

LGVN

Longeveron Inc
NASDAQ
6.92
-0.41
-5.59%
Pre Market: 7.05 +0.13 +1.88% 08:56 09/15 EDT
OPEN
7.20
PREV CLOSE
7.33
HIGH
7.60
LOW
6.92
VOLUME
248
TURNOVER
0
52 WEEK HIGH
12.30
52 WEEK LOW
4.750
MARKET CAP
22.06M
P/E (TTM)
-0.6745
1D
5D
1M
3M
1Y
5Y
1D
Longeveron Regains Nasdaq Compliance With Minimum Bid Price
TipRanks · 17h ago
Weekly Report: what happened at LGVN last week (0907-0911)?
Weekly Report · 1d ago
Weekly Report: what happened at LGVN last week (0831-0904)?
Weekly Report · 09/07 09:57
Weekly Report: what happened at LGVN last week (0824-0828)?
Weekly Report · 08/31 10:02
Longeveron Inc trading halted, news pending
TipRanks · 08/26 23:50
Stock Market Today: Dow Jones, S&P 500 Futures Advance as Scott Bessent Expands Sanctions on Iran—Navitas Semiconductor, Gorilla Technology, Real Brokerage in Focus
Benzinga · 08/25 09:38
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
Benzinga · 08/25 08:02
Longeveron To Enter 1-for-10 Reverse Stock Split For Minimum Bid Price Compliance; Shares Plunge
NASDAQ · 08/25 06:59
More
About LGVN
Longeveron Inc. is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action, encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. The Company is pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. Lomecel-B development programs have received five distinct FDA designations: for the HLHS program - Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program - Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation.

Webull offers Longeveron Inc stock information, including NASDAQ: LGVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGVN stock methods without spending real money on the virtual paper trading platform.